HOSPITAL MORTALITY IN PATIENTS WITH DIABETES MELLITUS TYPE 2. HOSPITAL Dr. GUSTAVO NELSON COLLADO RIOS - CHITRE. JANUARY - DECEMBER, 2016
Article Sidebar
Main Article Content
Abstract
Background: Hospital mortality in diabetics ranges from 8.96% to 21.7%; Its main causes are: cardiovascular, infectious and metabolic.
Oajectives: To describe the characteristics of in-hospital mortality in patients with Type 2 Diabetes Mellitus at the Dr. Gustavo Nelson Collado Ríos Hospital in the city of Chitré, from January to December 2016. We will investigate the Mortality Rate, Age, Sex, Cause of Death and Comorbidities.
Methods: Quantitative, descriptive and retrospective study. Clinical records and death certificates were reviewed. A survey was applied to each file designed according to the study variables.
Results: We found a total of 60 deaths. Specific hospital mortality rate = 13%. Average age 72 +/- 11. Male sex = 45% (N 27), female 55% (N 33). Cause of death: low respiratory tract infection (25% n 14), chronic kidney disease (20% n 11), acute coronary syndrome (14% n 8), soft tissue infection (13% n 7) and vascular brain event (7% n 4). Comorbidities: chronic kidney disease 42%, arterial hypertension 21%, heart diseases 18% and squeals of vascular brain event 8%.
Conclusion: The characteristics of hospital mortality in patients with type 2 diabetes mellitus (DM) are similar to those reported by Latin American studies and in Spain. The main ones are associated with infectious etiologies, chronic kidney disease and acute coronary syndromes. Therefore, it is necessary to optimize the prevention, diagnosis, treatment and monitoring of patients with DM who are hospitalized for any of these causes or acquire it in-hospital.
Downloads
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
References
1. Andrews, K. et al. Wound management of chronic diabetic foot ulcers: From the basics to regenerative medicine. Prosthetics and Orthotics International 2015;39: 29–39.
2. Bourne, R., et al. Causes of vision loss worldwide, 1990-2010: A systematic analysis. Lancet global health 2013;1:339-349.
3. Centers for disease control and prevention. National diabetes statis¬tics report: estimates of diabetes and its burden in the United States, 2014. Atlanta. U.S. Department of health and human services, 2014.
4. Chen, k. et al. Causes of death and associated factors among patients with non-insulin-dependent diabetes mellitus in Taiwan. Diabetes Res ClinPract, 1999;43:101-109.
5. Gonzales-Grández, N. et al. Clinical features and associated factors to intrahospital morbidity in patients with type 2 diabetes mellitus. Rev Soc Peru Med Interna, 2013;26: 3-7.
6. International Diabetes Federation. Atlas de la diabetes. 7th ed. Brussels, Belgium. International Diabetes Federation, 2015.
7. Inzucchi, E., et al. Diabetes mellitus tipo 2. Cecil y Goldman, Tratado de Medicina Interna. España: Elsevier; 2013. p. 1494-1504.
8. Jameson, J. et al. Type 2 diabetes mellitus. Endocrinology: adult and pediatric Seventh Edition. Philadelphia: Elsevier; 2016. p. 1385-1450.
9. Mc Donald, P. et al. Prevalence, sociodemographic distribution, treatment and control of diabetes mellitus in Panamá. Diabetology & metabolic syndrome. 2013; 5: 69.
10. Membreño, J. et al. Hospitalización de pacientes con diabetes mellitus. Causas, complicaciones y mortalidad. Rev Med IMSS Mexico, 2005; 43: 97-101.
11. Ministerio de salud. Dirección nacional de planificación, departamento de registros médicos y estadísticas de salud, indicadores generales de la región de salud de herrera, año: 2000 – 2013. Indicadores Básicos de Salud en la República de Panamá por provincia 2014, Sección provincia de Herrera.
12. Ministerio de Salud de Panamá. MINSA. Dirección de Planificación; Departamento de Registro y Estadística de Salud. Prevalencia de factores de riesgos asociados a enfermedades cardiovasculares en la población de 18 años y más de edad de las provincias de Panamá y Colón 2010. Indicadores Básicos de Salud en la República de Panamá, 2014.
13. National institute of diabetes and digestive and kidney diseases.USRDS annual data report: epidemiology of kidney disease in the United States. National institutes of health 2014;188–210.
14. Organización Mundial de la Salud. (2016). Informe mundial sobre diabetes para el año 2016. Recuperado el 15 de enero de 2017, de Http://www.who.int/diabetes/ global-report/es/
15. Organización Mundial de Salud. (2016). Diabetes Nota descriptiva Noviembre de 2016, Datos y cifras. Recuperado el 15 de enero de 2017, de Http://www.who.int/ mediacentre/factsheets/fs312/es/
16. Organización Mundial de la Salud. (2016). Perfiles de los países para la diabetes, 2016. Recuperado el 15 de enero 2016, de Http://www.who.int/diabetes/country- profiles/es/
17. Organización Mundial de la Salud. (1999). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, Ginebra, 1999. Report number: who/ncd/ncs/99.2. Recurado el 15 de enero de 2017, de Http://www.who.int/diabetes/global-report/es/
18. Organización Panamericana de la Salud. Situación de salud en las Américas. Indicadores básicos de salud 2011. Washington, 2011.
19. Pérez-Barquero, M. et al. Factores pronósticos en pacientes con diabetes mellitus tipo 2 ingresados en servicios de medicina interna: Mortalidad y reingreso hospitalario en un año. Rev Clin Esp.,2007; 207: 22-30
20. Sarwar, N., et al. Diabetes Mellitus, fasting blood glucose concentration, and risk of vascular disease. Lancet, 2010;26: 2215-2222.
21. Shaw, J., et al. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res ClinPract, 2010; 87: 4-14.
22. William. T. et al. American Diabetes Association. Standards of medical care in Diabetes 2016. Diabetes care. 2016; 39:1-109.